New CEO at AcelRx Pharmaceuticals
This article was originally published in Scrip
Executive Summary
AcelRx Pharmaceuticals (US) has named Richard King president and chief executive officer. He will lead the company's efforts to advance its portfolio of products using its NanoTab platform technology. Mr King was previously president and general manager of Tercica, a biotechnology company focused on endocrinology and neurology products, which was acquired by Ipsen in 2008.